Integrated Filing — IndAS



General information about company
Scrip Code 524669
NSE Symbol HESTERBIO
MSEI Symbol NOTLISTED
ISIN INE782E01017
Name of company HESTER BIOSCIENCES LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2025
Date of end of financial year 31-Mar-2026
Date of board meeting when results were approved 01-Aug-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 23-Jul-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter First quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 01-Aug-2025   11:30:00
End date and time of board meeting 01-Aug-2025   12:10:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 841050000
Other income 23160000
Total income 864210000
2 Expenses
(a) Cost of materials consumed 135580000
(b) Purchases of stock-in-trade 45870000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 43170000
(d) Employee benefit expense 152820000
(e) Finance costs 18100000
(f) Depreciation, depletion and amortisation expense 41820000
(f) Other Expenses
1 Other expenses 235470000 235470000
Total other expenses 235470000
Total expenses 672830000
3 Total profit before exceptional items and tax 191380000
4 Exceptional items 0
5 Total profit before tax 191380000
6 Tax expense
7 Current tax 21550000
8 Deferred tax 7360000
9 Total tax expenses 28910000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0
11 Net Profit Loss for the period from continuing operations 162470000
12 Profit (loss) from discontinued operations before tax 0
13 Tax expense of discontinued operations 0
14 Net profit (loss) from discontinued operation after tax 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 10490000
16 Total profit (loss) for period 172960000
17 Other comprehensive income net of taxes -1760000
18 Total Comprehensive Income for the period 171200000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 164420000
Total profit or loss, attributable to non-controlling interests 8540000
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 162710000
Total comprehensive income for the period attributable to owners of parent non-controlling interests 8490000
21 Details of equity share capital
Paid-up equity share capital 85070000
Face value of equity share capital 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 20.33
Diluted earnings (loss) per share from continuing operations 20.33
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0
Diluted earnings (loss) per share from discontinued operations 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 20.33
Diluted earnings (loss) per share from continuing and discontinued operations 20.33
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results
Textual Information(1) Please visit Company and stock exchanges website for the detailed financil results and relevant notes as PDF disclosure.



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2025
Date of end of reporting period 30-Jun-2025
Whether accounts are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Poultry Healthcare 421220000 421220000
2 Animal Healthcare 419830000 419830000
Total Segment Revenue 841050000
Less: Inter segment revenue 0 0
Revenue from operations 841050000
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Poultry Healthcare 92290000 92290000
2 Animal Healthcare 132110000 132110000
Total Profit before tax 224400000
i. Finance cost 18100000 18100000
ii. Other Unallocable Expenditure net off Unallocable income 4430000 4430000
Profit before tax 201870000
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Poultry Healthcare 2436090000 2436090000
2 Animal Healthcare 2128700000 2128700000
Total Segment Asset 4564790000 4564790000
Un-allocable Assets 2056940000 2056940000
Net Segment Asset 6621730000 6621730000
4 Segment Liabilities
Segment Liabilities
1 Poultry Healthcare 135090000 135090000
2 Animal Healthcare 363160000 363160000
Total Segment Liabilities 498250000 498250000
Un-allocable Liabilities 2685720000 2685720000
Net Segment Liabilities 3183970000 3183970000
Disclosure of notes on segments Textual Information(2)



Text Block
Textual Information(2) Please visit Company and stock exchanges website for the detailed financil results and relevant notes as PDF disclosure.



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement Gain/(Loss) on Defined Benefit Plans -1360000 -1360000
Total Amount of items that will not be reclassified to profit and loss -1360000
2 Income tax relating to items that will not be reclassified to profit or loss -350000
3 Amount of items that will be reclassified to profit and loss
1 Foreign Currency Translation Reserve -750000 -750000
Total Amount of items that will be reclassified to profit and loss -750000
4 Income tax relating to items that will be reclassified to profit or loss 0
5 Total Other comprehensive income -1760000